About
Genome-editing enzymes, CAR-T
Areas of Focus
Categories
Stem Cell & Cellular TherapyNorth & South Carolina
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
124
By Phase
PHASE1: 3PHASE1/PHASE2: 1
By Status
COMPLETED: 2RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06680232Lead Sponsor
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
PHASE1Recruiting
45 participants
Started: Nov 14, 2024 · Completed: Dec 31, 2026
NCT04649112Lead Sponsor
Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies
PHASE1Completed
13 participants
Started: Jun 16, 2021 · Completed: Sep 30, 2023
NCT04171843Lead Sponsor
A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma
PHASE1Terminated
48 participants
Started: Apr 30, 2020 · Completed: Oct 19, 2022
NCT04030195Lead Sponsor
Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL
PHASE1/PHASE2Completed
18 participants
Started: Mar 24, 2020 · Completed: Jun 24, 2021
Locations (1)
Headquarters
Durham, NC, United States
Map
Loading map...